162 related articles for article (PubMed ID: 15269184)
1. Two major grapefruit juice components differ in intestinal CYP3A4 inhibition kinetic and binding properties.
Paine MF; Criss AB; Watkins PB
Drug Metab Dispos; 2004 Oct; 32(10):1146-53. PubMed ID: 15269184
[TBL] [Abstract][Full Text] [Related]
2. Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibition.
Paine MF; Criss AB; Watkins PB
J Pharmacol Exp Ther; 2005 Mar; 312(3):1151-60. PubMed ID: 15485894
[TBL] [Abstract][Full Text] [Related]
3. Inhibition selectivity of grapefruit juice components on human cytochromes P450.
Tassaneeyakul W; Guo LQ; Fukuda K; Ohta T; Yamazoe Y
Arch Biochem Biophys; 2000 Jun; 378(2):356-63. PubMed ID: 10860553
[TBL] [Abstract][Full Text] [Related]
4. 6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect.
Kakar SM; Paine MF; Stewart PW; Watkins PB
Clin Pharmacol Ther; 2004 Jun; 75(6):569-79. PubMed ID: 15179411
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.
Schmiedlin-Ren P; Edwards DJ; Fitzsimmons ME; He K; Lown KS; Woster PM; Rahman A; Thummel KE; Fisher JM; Hollenberg PF; Watkins PB
Drug Metab Dispos; 1997 Nov; 25(11):1228-33. PubMed ID: 9351897
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins.
Girennavar B; Jayaprakasha GK; Patil BS
J Food Sci; 2007 Oct; 72(8):C417-21. PubMed ID: 17995595
[TBL] [Abstract][Full Text] [Related]
7. 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein.
Edwards DJ; Fitzsimmons ME; Schuetz EG; Yasuda K; Ducharme MP; Warbasse LH; Woster PM; Schuetz JD; Watkins P
Clin Pharmacol Ther; 1999 Mar; 65(3):237-44. PubMed ID: 10096255
[TBL] [Abstract][Full Text] [Related]
8. Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice.
Greenblatt DJ; von Moltke LL; Harmatz JS; Chen G; Weemhoff JL; Jen C; Kelley CJ; LeDuc BW; Zinny MA
Clin Pharmacol Ther; 2003 Aug; 74(2):121-9. PubMed ID: 12891222
[TBL] [Abstract][Full Text] [Related]
9. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity.
Guo LQ; Fukuda K; Ohta T; Yamazoe Y
Drug Metab Dispos; 2000 Jul; 28(7):766-71. PubMed ID: 10859150
[TBL] [Abstract][Full Text] [Related]
10. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.
Bailey DG; Dresser GK; Bend JR
Clin Pharmacol Ther; 2003 Jun; 73(6):529-37. PubMed ID: 12811362
[TBL] [Abstract][Full Text] [Related]
11. Screening of furanocoumarin derivatives as cytochrome P450 3A4 inhibitors in citrus.
Masuda M; Watanabe S; Tanaka M; Tanaka A; Araki H
J Clin Pharm Ther; 2018 Feb; 43(1):15-20. PubMed ID: 28749005
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4.
Row EC; Brown SA; Stachulski AV; Lennard MS
Org Biomol Chem; 2006 Apr; 4(8):1604-10. PubMed ID: 16604230
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
Eagling VA; Profit L; Back DJ
Br J Clin Pharmacol; 1999 Oct; 48(4):543-52. PubMed ID: 10583025
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CYP3A4 by 6',7'-dihydroxybergamottin in human CYP3A4 over-expressed hepG2 cells.
Araki N; Tsuruoka S; Hasegawa G; Yanagihara H; Omasa T; Enosawa S; Yamazoe Y; Fujimura A
J Pharm Pharmacol; 2012 Dec; 64(12):1715-21. PubMed ID: 23146034
[TBL] [Abstract][Full Text] [Related]
15. Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine.
Paine MF; Widmer WW; Pusek SN; Beavers KL; Criss AB; Snyder J; Watkins PB
Am J Clin Nutr; 2008 Apr; 87(4):863-71. PubMed ID: 18400708
[TBL] [Abstract][Full Text] [Related]
16. Processing grapefruit juice with γ-cyclodextrin attenuates its inhibitory effect on cytochrome P450 3A activity.
Yamasaki K; Iohara D; Oyama Y; Nishizaki N; Kawazu S; Nishi K; Kadowaki D; Taguchi K; Otagiri M; Seo H
J Pharm Pharmacol; 2020 Mar; 72(3):356-363. PubMed ID: 31828807
[TBL] [Abstract][Full Text] [Related]
17. New grapefruit cultivars exhibit low cytochrome P4503A4-Inhibition activity.
Guttman Y; Yedidia I; Nudel A; Zhmykhova Y; Kerem Z; Carmi N
Food Chem Toxicol; 2020 Mar; 137():111135. PubMed ID: 31968226
[TBL] [Abstract][Full Text] [Related]
18. Major furocoumarins in grapefruit juice II: phototoxicity, photogenotoxicity, and inhibitory potency vs. cytochrome P450 3A4 activity.
Messer A; Raquet N; Lohr C; Schrenk D
Food Chem Toxicol; 2012 Mar; 50(3-4):756-60. PubMed ID: 22155270
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a candidate marker constituent predictive of a dietary substance-drug interaction: case study with grapefruit juice and CYP3A4 drug substrates.
Ainslie GR; Wolf KK; Li Y; Connolly EA; Scarlett YV; Hull JH; Paine MF
J Pharmacol Exp Ther; 2014 Dec; 351(3):576-84. PubMed ID: 25253884
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine.
Chan WK; Nguyen LT; Miller VP; Harris RZ
Life Sci; 1998; 62(10):PL135-42. PubMed ID: 9496718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
